CTSZ has also been explored for prognostic value and roles in tumor progression across many cancers [86], including breast [87], colorectal [88], gastric [77], and prostate cancers [89], and hepatocellular carcinoma [90]. The gene discussed is CTSZ; the disease is prostate carcinoma.